Clariant AG (OTCMKTS:CLZNY – Get Free Report) was the target of a significant decline in short interest in February. As of February 28th, there was short interest totalling 300 shares, a decline of 82.4% from the February 13th total of 1,700 shares. Based on an average daily volume of 4,600 shares, the short-interest ratio is presently 0.1 days.
Clariant Stock Down 4.1 %
Shares of Clariant stock traded down $0.49 during trading on Wednesday, reaching $11.59. The company’s stock had a trading volume of 702 shares, compared to its average volume of 1,872. The business has a 50 day moving average price of $11.85 and a 200-day moving average price of $13.17. Clariant has a 12-month low of $10.71 and a 12-month high of $17.47.
Analyst Upgrades and Downgrades
CLZNY has been the topic of a number of research reports. Deutsche Bank Aktiengesellschaft restated a “hold” rating on shares of Clariant in a research report on Wednesday, March 5th. Berenberg Bank downgraded shares of Clariant from a “strong-buy” rating to a “hold” rating in a research report on Monday, March 3rd. Finally, Citigroup reaffirmed a “buy” rating on shares of Clariant in a report on Tuesday.
About Clariant
Clariant AG engages in the development, manufacture, distribution, and sale of specialty chemicals worldwide. The Care Chemicals segment offers specialty chemicals and application solutions for various applications in automotive fluids, aviation, construction chemicals, crop solutions, health care, home care, industrial lubricants, paints and coatings, personal care, and special solvents.
Featured Stories
- Five stocks we like better than Clariant
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- NVIDIA’s Soaring Energy Needs Make These 3 Nuclear Stocks a Buy
- Insider Trading – What You Need to Know
- Why Energy Transfer Belongs on Your Watchlist
- Growth Investing: Should You Adopt This Investing Strategy in 2022?
- Why Wayfair Stock May Be a Hidden Gem for Value Investors
Receive News & Ratings for Clariant Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clariant and related companies with MarketBeat.com's FREE daily email newsletter.